Q4 2025 Management View CEO Lishan Aklog reported that "our EsoGuard test volume in the fourth quarter was 3,664. That exceeds our target range that we've articulated regularly of approximately 2,500 ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
Digital Volume Correlation (DVC) has emerged as a transformative technique in the evaluation of internal strains and displacements in biological tissues and engineered materials. By utilising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results